Abhishek Singh, CEO of MyGovIndia that developed Aarogya Setu, says data will be used only for critical purposes such as medical emergencies, app won't share Covid patient info.
The experimental antiviral drug that was developed by US pharmaceutical company Gilead Sciences has shown that it leads to faster recovery in Covid-19 patients.
CSIR will launch trials to see if sepsis drug can stop Covid-19 from progressing in asymptomatic patients & if it can prevent it from redeveloping in recovered patients.
Indian ambassador to US Taranjit Singh Sandhu says the bilateral partnership will focus more on healthcare and pharma sectors in a post-pandemic world.
People are looking at issues with ‘preemptive prejudice’, Chinese Embassy spokesperson says on ICMR asking states to not use test kits imported from 2 China firms.
The answer to if India is managing the coronavirus pandemic or is it getting out of hand keeps changing depending on the indicator one chooses to assess.
In a country where unemployment is at a historic high, the national anxiety isn’t about jobs — it’s about reach. Aspirations have shifted from employment to engagement, from careers to content.
COMMENTS